Article
Comparison of the effectiveness and toxicity of neoadjuvant chemotherapy regimens…
OncoTargets and Therapy · 2016 · Zhang MM, Wei W, Liu JL, Yang HW, Jiang Y, Tang W, Li QY, Liao XM
Key facts
| Title | Comparison of the effectiveness and toxicity of neoadjuvant chemotherapy regimens, capecitabine/epirubicin/cyclophosphamide vs 5-fluorouracil/epirubicin/cyclophosphamide, followed by adjuvant, capecitabine/docetaxel vs docetaxel, in patients with operable breast cancer |
|---|---|
| First author | Zhang MM, Wei W, Liu JL, Yang HW, Jiang Y, Tang W, Li QY, Liao XM |
| Journal | OncoTargets and Therapy |
| Published | Jun 8, 2016 |
| DOI | 10.2147/OTT.S104431 |
| Devices mentioned | K160007, K780428, K791373, K801244, K820613, K820614, K820942, K981792 |
| Product codes mentioned | CFE, FPA, JHI, JLW |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1